AC Immune (ACIU) Return on Sales [ROS] (2015 - 2026)
AC Immune's Return on Sales [ROS] came in at 7.89% for the quarter ended Jun 30, 2026, up 1492.43 percentage points from -1484.53% a year earlier and up 1329.43 percentage points from the prior quarter.
AC Immune (ACIU) Return on Sales [ROS] (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AC Immune reported Return on Sales [ROS] of -251.02%, down 77.84 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -1940.05%, down 1748.25 percentage points from the prior year.
- Return on Sales [ROS] carries a five-year change of -1543.06 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, Return on Sales [ROS] was -191.80% in the year ended Dec 31, 2024 (+170.50 pp), -362.30% in the year ended Dec 31, 2023 (+1438.13 pp) and -1800.43% in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Return on Sales [ROS] since the quarter ended Sep 30, 2024.
- Year-over-year, Return on Sales [ROS] increased in three of the last five quarters, with an average year-over-year change of -135.45 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in the quarter ended Sep 30, 2022 (a gain of 2113.34 percentage points), and the weakest in the quarter ended Dec 31, 2022 (a drop of 1865885.00 percentage points).
- Business Quant data shows ACIU's Return on Sales [ROS] at -1321.54% (quarter ended Mar 31, 2026), -4258.58% (quarter ended Dec 31, 2025) and -1721.62% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | AC Immune | 276.74 Mn | 276.74 Mn | - | 7.89% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.89% |
| Mar 31, 2026 | -1,321.54% |
| Dec 31, 2025 | -4,258.58% |
| Sep 30, 2025 | -1,721.62% |
| Jun 30, 2025 | -1,484.53% |
| Mar 31, 2025 | -1,956.57% |
| Dec 31, 2024 | -1,637.47% |
| Sep 30, 2024 | 28.52% |
| Jun 30, 2024 | -3,051.09% |
| Dec 31, 2022 | -1,869,700.00% |
| Sep 30, 2022 | -342.22% |
| Jun 30, 2022 | -8,409.42% |
| Dec 31, 2021 | -3,815.00% |
| Sep 30, 2021 | -2,455.56% |
| Dec 31, 2020 | -2,061.97% |
| Sep 30, 2020 | -1,674.53% |
| Jun 30, 2020 | -1,448.48% |
| Mar 31, 2020 | -59.46% |
| Dec 31, 2019 | -2,188.72% |
| Sep 30, 2019 | 53.81% |
AC Immune Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();